— Know what they know.
Not Investment Advice
Also trades as: 0I0X.L (LSE) · $vol 0M

CDXS NASDAQ

Codexis, Inc.
1W: -1.6% 1M: +2.4% 3M: +116.2% YTD: +57.1% 1Y: +3.3% 3Y: -3.4% 5Y: -86.2%
$2.49
-0.04 (-1.58%)
 
Weekly Expected Move ±11.6%
$2 $2 $2 $3 $3
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 48 · $226.3M mcap · 73M float · 3.25% daily turnover · Short 42% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$70M +18.6% ▲
5Y CAGR: +0.4%
Gross Profit
$56M +29.9% ▲
5Y CAGR: +0.2%
Operating Income
-$38M +34.5% ▲
Net Income
-$44M +32.6% ▲
EPS (Diluted)
$-0.50 +43.8% ▲
EBITDA
-$30M +48.7% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$105M$139M$70M$59M$70M
YoY Growth+51.7%+32.3%-49.4%-15.4%+18.6%
Cost of Revenue$22M$38M$13M$16M$14M
Gross Profit$83M$101M$57M$43M$56M
Gross Margin78.8%72.6%81.7%72.6%79.5%
R&D Expenses$56M$80M$59M$46M$44M
SG&A Expenses$49M$52M$53M$55M$47M
Operating Expenses$105M$135M$125M$102M$94M
Operating Income-$23M-$35M-$68M-$59M-$38M
Operating Margin-21.7%-25.2%-97.0%-98.6%-54.5%
Interest Expense$0$0$0$0$5M
Income Before Tax-$21M-$33M-$76M-$65M-$44M
Tax Expense$189K$276K$69K$34K$47K
Net Income-$21M-$34M-$76M-$65M-$44M
Net Margin-20.3%-24.2%-108.7%-110.0%-62.5%
EPS (Diluted)$-0.33$-0.51$-1.12$-0.89$-0.50
EBITDA-$17M-$26M-$49M-$59M-$30M
Shares Outstanding65M65M68M73M87M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms